Artiva Biotherapeutics公司定价发行2390万股普通股 每股11.52美元及220万份预融资权证 每股11.5199美元

美股速递
May 08

生物技术企业Artiva Biotherapeutics Inc(股票代码:ARTV)正式公布其新股发行定价方案。根据公告,公司将以每股11.52美元的价格公开发行2390万股普通股,同时以每股11.5199美元的定价配售220万份预融资权证。此次融资将为企业后续研发管线推进提供资金支持。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10